{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:42:52Z","timestamp":1791985372320,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","award":["CRI3370"],"award-info":[{"award-number":["CRI3370"]}],"id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R61 CA281807"],"award-info":[{"award-number":["R61 CA281807"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R61 CA281807"],"award-info":[{"award-number":["R61 CA281807"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R61 CA281807"],"award-info":[{"award-number":["R61 CA281807"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R61 CA281807"],"award-info":[{"award-number":["R61 CA281807"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R61 CA281807"],"award-info":[{"award-number":["R61 CA281807"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R61 CA281807"],"award-info":[{"award-number":["R61 CA281807"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R61 CA281807"],"award-info":[{"award-number":["R61 CA281807"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R61 CA281807"],"award-info":[{"award-number":["R61 CA281807"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R61 CA281807"],"award-info":[{"award-number":["R61 CA281807"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46452-7","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T14:19:13Z","timestamp":1775657953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["An affinity reagent-conjugated biotin ligase for amplified cell surface labelling in vitro and in vivo"],"prefix":"10.1038","volume":"16","author":[{"given":"Beck","family":"Holden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Mutaher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raktima","family":"Raychowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Bakalar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Olajide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Hacohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"46452_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40364-019-0178-7","volume":"7","author":"D Liu","year":"2019","unstructured":"Liu, D. Cancer biomarkers for targeted therapy. Biomark. Res. 7, 25 (2019).","journal-title":"Biomark. Res."},{"key":"46452_CR2","doi-asserted-by":"publisher","first-page":"626616","DOI":"10.3389\/fimmu.2021.626616","volume":"12","author":"J Ma","year":"2021","unstructured":"Ma, J. et al. Bispecific antibodies: From research to clinical application. Front. Immunol. 12, 626616 (2021).","journal-title":"Front. Immunol."},{"key":"46452_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1146\/annurev-med-061516-121357","volume":"69","author":"JM Lambert","year":"2018","unstructured":"Lambert, J. M. & Berkenblit, A. Antibody\u2013drug conjugates for cancer treatment. Annu. Rev. Med. 69, 191\u2013207 (2018).","journal-title":"Annu. Rev. Med."},{"key":"46452_CR4","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s12967-023-04292-3","volume":"21","author":"G Dagar","year":"2023","unstructured":"Dagar, G. et al. Harnessing the potential of CAR-T cell therapy: Progress, challenges, and future directions in hematological and solid tumor treatments. J. Transl. Med. 21, 449 (2023).","journal-title":"J. Transl. Med."},{"key":"46452_CR5","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3390\/v15030698","volume":"15","author":"K Lundstrom","year":"2023","unstructured":"Lundstrom, K. Viral vectors in gene therapy: Where do we stand in 2023?. Viruses 15, 698 (2023).","journal-title":"Viruses"},{"key":"46452_CR6","doi-asserted-by":"publisher","first-page":"9500","DOI":"10.1021\/acsami.0c05750","volume":"13","author":"S Ni","year":"2021","unstructured":"Ni, S. et al. Recent progress in aptamer discoveries and modifications for therapeutic applications. ACS Appl. Mater. Interfaces 13, 9500\u20139519 (2021).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"46452_CR7","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1038\/s41467-020-16920-3","volume":"11","author":"AJ Quartararo","year":"2020","unstructured":"Quartararo, A. J. et al. Ultra-large chemical libraries for the discovery of high-affinity peptide binders. Nat. Commun. 11, 3183 (2020).","journal-title":"Nat. Commun."},{"key":"46452_CR8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","volume":"19","author":"TC Roberts","year":"2020","unstructured":"Roberts, T. C., Langer, R. & Wood, M. J. A. Advances in oligonucleotide drug delivery. Nat. Rev. Drug Discov. 19, 673\u2013694 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"46452_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/tan.13789","author":"A Christophersen","year":"2019","unstructured":"Christophersen, A. Peptide-MHC class I and class II tetramers: From flow to mass cytometry. HLA https:\/\/doi.org\/10.1111\/tan.13789 (2019).","journal-title":"HLA"},{"key":"46452_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/978-1-4939-7346-0_7","volume":"1678","author":"J Paterson","year":"2018","unstructured":"Paterson, J. & Ailles, L. E. High throughput flow cytometry for cell surface profiling. Methods Mol. Biol. Clifton N. J. 1678, 111\u2013138 (2018).","journal-title":"Methods Mol. Biol. Clifton N. J."},{"key":"46452_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41591-020-0752-4","volume":"26","author":"M Reyes","year":"2020","unstructured":"Reyes, M. et al. An immune cell signature of bacterial sepsis. Nat. Med. 26, 333\u2013340 (2020).","journal-title":"Nat. Med."},{"key":"46452_CR12","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.3390\/life12111937","volume":"12","author":"X Hu","year":"2022","unstructured":"Hu, X. et al. Aptamer-based probes for cancer diagnostics and treatment. Life 12, 1937 (2022).","journal-title":"Life"},{"key":"46452_CR13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13045-020-00910-5","volume":"13","author":"R Huang","year":"2020","unstructured":"Huang, R. et al. Recent advances in CAR-T cell engineering. J. Hematol. Oncol. J Hematol. Oncol. 13, 86 (2020).","journal-title":"J. Hematol. Oncol. J Hematol. Oncol."},{"issue":"200","key":"46452_CR14","first-page":"2263","volume":"1950","author":"C Rius","year":"2018","unstructured":"Rius, C. et al. Peptide-MHC class I tetramers can fail to detect relevant functional T cell clonotypes and underestimate antigen-reactive T cell populations. J. Immunol. Baltim. Md 1950(200), 2263\u20132279 (2018).","journal-title":"J. Immunol. Baltim. Md"},{"key":"46452_CR15","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s12325-017-0519-6","volume":"34","author":"JM Lambert","year":"2017","unstructured":"Lambert, J. M. & Morris, C. Q. Antibody-drug conjugates (ADCs) for personalized treatment of solid tumors: A review. Adv. Ther. 34, 1015\u20131035 (2017).","journal-title":"Adv. Ther."},{"key":"46452_CR16","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/19420862.2016.1156829","volume":"8","author":"H Donaghy","year":"2016","unstructured":"Donaghy, H. Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates. MAbs 8, 659\u2013671 (2016).","journal-title":"MAbs"},{"key":"46452_CR17","doi-asserted-by":"publisher","first-page":"770","DOI":"10.2214\/AJR.20.22837","volume":"215","author":"R Thomas","year":"2020","unstructured":"Thomas, R., Howard, S. A., Laferriere, S. L. & Braschi-Amirfarzan, M. A review of the mechanisms and clinical implications of precision cancer therapy-related toxicity: A primer for the radiologist. AJR Am. J. Roentgenol. 215, 770\u2013780 (2020).","journal-title":"AJR Am. J. Roentgenol."},{"key":"46452_CR18","doi-asserted-by":"publisher","first-page":"a030338","DOI":"10.1101\/cshperspect.a030338","volume":"10","author":"J Zhu","year":"2018","unstructured":"Zhu, J. T helper cell differentiation, heterogeneity, and plasticity. Cold Spring Harb. Perspect. Biol. 10, a030338 (2018).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"46452_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.immuni.2018.02.010","volume":"48","author":"SC Jameson","year":"2018","unstructured":"Jameson, S. C. & Masopust, D. Understanding subset diversity in T cell memory. Immunity 48, 214\u2013226 (2018).","journal-title":"Immunity"},{"key":"46452_CR20","doi-asserted-by":"publisher","first-page":"eaah4573","DOI":"10.1126\/science.aah4573","volume":"356","author":"A-C Villani","year":"2017","unstructured":"Villani, A.-C. et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science 356, eaah4573 (2017).","journal-title":"Science"},{"key":"46452_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.semcdb.2017.12.009","volume":"84","author":"C Macri","year":"2018","unstructured":"Macri, C., Pang, E. S., Patton, T. & O\u2019Keeffe, M. Dendritic cell subsets. Semin. Cell Dev. Biol. 84, 11\u201321 (2018).","journal-title":"Semin. Cell Dev. Biol."},{"key":"46452_CR22","first-page":"1","volume":"9","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y. et al. Tumor biomarkers for diagnosis, prognosis and targeted therapy. Signal Transduct. Target. Ther. 9, 1\u201386 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"46452_CR23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12967-020-02243-w","volume":"18","author":"S Padthaisong","year":"2020","unstructured":"Padthaisong, S. et al. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma. J. Transl. Med. 18, 64 (2020).","journal-title":"J. Transl. Med."},{"key":"46452_CR24","doi-asserted-by":"publisher","first-page":"1035276","DOI":"10.3389\/fimmu.2022.1035276","volume":"13","author":"J Wei","year":"2022","unstructured":"Wei, J., Yang, Y., Wang, G. & Liu, M. Current landscape and future directions of bispecific antibodies in cancer immunotherapy. Front. Immunol. 13, 1035276 (2022).","journal-title":"Front. Immunol."},{"key":"46452_CR25","doi-asserted-by":"publisher","first-page":"5632","DOI":"10.3390\/ijms22115632","volume":"22","author":"M Elshiaty","year":"2021","unstructured":"Elshiaty, M., Schindler, H. & Christopoulos, P. Principles and current clinical landscape of multispecific antibodies against cancer. Int. J. Mol. Sci. 22, 5632 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"46452_CR26","doi-asserted-by":"publisher","first-page":"2034355","DOI":"10.1080\/2162402X.2022.2034355","volume":"11","author":"A Tapia-Galisteo","year":"2022","unstructured":"Tapia-Galisteo, A. et al. Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer. Oncoimmunology 11, 2034355 (2022).","journal-title":"Oncoimmunology"},{"key":"46452_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/science.aba6527","author":"MJ Lajoie","year":"2020","unstructured":"Lajoie, M. J. et al. Designed protein logic to target cells with precise combinations of surface antigens. Science https:\/\/doi.org\/10.1126\/science.aba6527 (2020).","journal-title":"Science"},{"key":"46452_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/imm.12499","volume":"146","author":"G Dolton","year":"2015","unstructured":"Dolton, G. et al. More tricks with tetramers: A practical guide to staining T cells with peptide\u2013MHC multimers. Immunology 146, 11\u201322 (2015).","journal-title":"Immunology"},{"key":"46452_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/cas.13854","volume":"110","author":"K Watanabe","year":"2019","unstructured":"Watanabe, K. et al. Development of a T-cell receptor multimer with high avidity for detecting a naturally presented tumor-associated antigen on osteosarcoma cells. Cancer Sci. 110, 40\u201351 (2019).","journal-title":"Cancer Sci."},{"key":"46452_CR30","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1369\/jhc.6A7134.2007","volume":"55","author":"ZE T\u00f3th","year":"2007","unstructured":"T\u00f3th, Z. E. & Mezey, E. Simultaneous visualization of multiple antigens with tyramide signal amplification using antibodies from the same species. J. Histochem. Cytochem. 55, 545\u2013554 (2007).","journal-title":"J. Histochem. Cytochem."},{"key":"46452_CR31","unstructured":"Alhajj, M., Zubair, M. & Farhana, A. Enzyme linked immunosorbent assay. In StatPearls (StatPearls Publishing, Treasure Island (FL) (2024)."},{"key":"46452_CR32","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1021\/acs.biochem.9b00791","volume":"59","author":"TMT Nguyen","year":"2020","unstructured":"Nguyen, T. M. T., Kim, J., Doan, T. T., Lee, M.-W. & Lee, M. APEX proximity labeling as a versatile tool for biological research. Biochemistry 59, 260\u2013269 (2020).","journal-title":"Biochemistry"},{"key":"46452_CR33","doi-asserted-by":"publisher","first-page":"667067","DOI":"10.3389\/fmolb.2021.667067","volume":"8","author":"S Hernandez","year":"2021","unstructured":"Hernandez, S. et al. Multiplex immunofluorescence tyramide signal amplification for immune cell profiling of paraffin-embedded tumor tissues. Front. Mol. Biosci. 8, 667067 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"46452_CR34","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1038\/s41467-025-57767-w","volume":"16","author":"Z Zhang","year":"2025","unstructured":"Zhang, Z. et al. Spatiotemporally resolved mapping of extracellular proteomes via in vivo-compatible TyroID. Nat. Commun. 16, 2553 (2025).","journal-title":"Nat. Commun."},{"key":"46452_CR35","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1038\/s41589-025-01973-6","volume":"21","author":"S-Y Lee","year":"2025","unstructured":"Lee, S.-Y. et al. Directed evolution of LaccID for cell surface proximity labeling and electron microscopy. Nat. Chem. Biol. 21, 1895\u20131905 (2025).","journal-title":"Nat. Chem. Biol."},{"key":"46452_CR36","doi-asserted-by":"publisher","first-page":"1700002","DOI":"10.1002\/pmic.201700002","volume":"17","author":"P Li","year":"2017","unstructured":"Li, P., Li, J., Wang, L. & Di, L.-J. Proximity labeling of interacting proteins: Application of BioID as a discovery tool. Proteomics 17, 1700002 (2017).","journal-title":"Proteomics"},{"key":"46452_CR37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jprot.2014.09.029","volume":"118","author":"D Dingar","year":"2015","unstructured":"Dingar, D. et al. BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. J. Proteom 118, 95\u2013111 (2015).","journal-title":"J. Proteom"},{"key":"46452_CR38","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1083\/jcb.201112098","volume":"196","author":"KJ Roux","year":"2012","unstructured":"Roux, K. J., Kim, D. I., Raida, M. & Burke, B. A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells. J. Cell Biol. 196, 801\u2013810 (2012).","journal-title":"J. Cell Biol."},{"key":"46452_CR39","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1091\/mbc.E15-12-0844","volume":"27","author":"DI Kim","year":"2016","unstructured":"Kim, D. I. et al. An improved smaller biotin ligase for BioID proximity labeling. Mol. Biol. Cell 27, 1188\u20131196 (2016).","journal-title":"Mol. Biol. Cell"},{"key":"46452_CR40","first-page":"2608","volume":"10","author":"A Chapman-Smith","year":"2001","unstructured":"Chapman-Smith, A., Mulhern, T. D., Whelan, F., Cronan, J. E. & Wallace, J. C. The C-terminal domain of biotin protein ligase from E. coli is required for catalytic activity. Protein Sci. 10, 2608\u20132617 (2001).","journal-title":"Protein Sci."},{"key":"46452_CR41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jmb.2008.12.086","volume":"387","author":"CM Tron","year":"2009","unstructured":"Tron, C. M. et al. Structural and functional studies of the biotin protein ligase from aquifex aeolicus reveal a critical role for a conserved residue in target specificity. J. Mol. Biol. 387, 129\u2013146 (2009).","journal-title":"J. Mol. Biol."},{"key":"46452_CR42","doi-asserted-by":"crossref","unstructured":"Final Report on the Safety Assessment of Biotin. Int. J. Toxicol. 20, 1\u201312 (2001).","DOI":"10.1080\/109158101529025472"},{"key":"46452_CR43","doi-asserted-by":"publisher","first-page":"50S","DOI":"10.1177\/10915818231221790","volume":"43","author":"P Cherian","year":"2024","unstructured":"Cherian, P. et al. Safety assessment of adenosine as used in cosmetics. Int. J. Toxicol. 43, 50S-63S (2024).","journal-title":"Int. J. Toxicol."},{"key":"46452_CR44","doi-asserted-by":"publisher","first-page":"104760","DOI":"10.1016\/j.yrtph.2020.104760","volume":"116","author":"R J\u00e4ger","year":"2020","unstructured":"J\u00e4ger, R., Purpura, M. & Fuller, J. C. Subchronic (90-day) repeated dose toxicity study of disodium adenosine-5\u2032-triphosphate in rats. Regul. Toxicol. Pharmacol. 116, 104760 (2020).","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"46452_CR45","doi-asserted-by":"publisher","first-page":"26523","DOI":"10.1073\/pnas.1909653116","volume":"116","author":"AH Keeble","year":"2019","unstructured":"Keeble, A. H. et al. Approaching infinite affinity through engineering of peptide\u2013protein interaction. Proc. Natl. Acad. Sci. 116, 26523\u201326533 (2019).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"46452_CR46","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nbt.4201","volume":"36","author":"TC Branon","year":"2018","unstructured":"Branon, T. C. et al. Efficient proximity labeling in living cells and organisms with TurboID. Nat. Biotechnol. 36, 880\u2013887 (2018).","journal-title":"Nat. Biotechnol."},{"key":"46452_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-022-03604-5","volume":"5","author":"L Kubitz","year":"2022","unstructured":"Kubitz, L. et al. Engineering of ultraID, a compact and hyperactive enzyme for proximity-dependent biotinylation in living cells. Commun. Biol. 5, 1\u201314 (2022).","journal-title":"Commun. Biol."},{"key":"46452_CR48","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.3390\/cells9112496","volume":"9","author":"V Vultaggio-Poma","year":"2020","unstructured":"Vultaggio-Poma, V., Sarti, A. C. & Di Virgilio, F. Extracellular ATP: A feasible target for cancer therapy. Cells 9, 2496 (2020).","journal-title":"Cells"},{"key":"46452_CR49","doi-asserted-by":"publisher","first-page":"108542","DOI":"10.1016\/j.celrep.2020.108542","volume":"33","author":"F Mimoto","year":"2020","unstructured":"Mimoto, F. et al. Exploitation of elevated extracellular ATP to specifically direct antibody to tumor microenvironment. Cell Rep. 33, 108542 (2020).","journal-title":"Cell Rep."},{"key":"46452_CR50","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1158\/2159-8290.CD-20-0328","volume":"11","author":"M Kamata-Sakurai","year":"2021","unstructured":"Kamata-Sakurai, M. et al. Antibody to CD137 activated by extracellular adenosine triphosphate is tumor selective and broadly effective in vivo without systemic immune activation. Cancer Discov. 11, 158\u2013175 (2021).","journal-title":"Cancer Discov."},{"key":"46452_CR51","doi-asserted-by":"publisher","first-page":"e1368604","DOI":"10.1080\/2162402X.2017.1368604","volume":"7","author":"JJ Lohmueller","year":"2017","unstructured":"Lohmueller, J. J., Ham, J. D., Kvorjak, M. & Finn, O. J. mSA2 affinity-enhanced biotin-binding CAR T cells for universal tumor targeting. Oncoimmunology 7, e1368604 (2017).","journal-title":"Oncoimmunology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46452-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46452-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46452-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T01:02:23Z","timestamp":1781485343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46452-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46452"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46452-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"B.H., N.H. and M.B. are co-authors on a patent filed by the Broad Institute related to the work presented in this manuscript. All the remaining authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18463"}}